{
    "info": {
        "nct_id": "NCT06630247",
        "official_title": "A Dose-escalation, Dose-finding, and Expansion Study of XL495 as a Single Agent and in Combination Therapy in Participants With Locally Advanced or Metastatic Solid Tumors",
        "inclusion_criteria": "Inclusion Criteria\n\n* For All Participants\n\n  * Have received at least one standard therapy unless it does not exist, or available therapies are intolerable or no longer effective.\n  * For participants, who qualify for approved molecularly selected therapies such as RAS inhibitors, they must have progressed on, relapsed from, been intolerant to, ineligible, or refused those therapies.\n* Expansion Stage\n\n  * Diagnosis of metastatic advanced UC (primary tumor: renal pelvis, ureter, urinary bladder, or urethra).\n  * At least one measurable lesion as defined by RECIST, version 1.1.\n  * Participants must be eligible for sacituzumab govitecan treatment as their next line of therapy.\n* At least one but no more than 3 prior lines of therapy.\n* Eastern Cooperative Oncology Group (ECOG) Performance Status (0-2 for monotherapy; 0-1 for combo)\n\nExclusion Criteria\n\n* Prior anticancer treatment, including:\n\n  * Radiation therapy within 2 weeks before first dose of study treatment.\n* Known brain metastases or cranial epidural disease\n* Current or recent severe illness\n* Known history or positive test for human immunodeficiency virus (HIV) unless meets specific criteria.\n* Active infection with hepatitis B virus or hepatitis C virus.\n* Malabsorption syndrome.\n* History of solid organ, autologous or allogenic stem cell transplant.\n* Diagnosis of another cancer within 2 years before first dose of study treatment, except for superficial skin cancers, or localized, low-grade tumors deemed cured and not treated with standard therapy.\n* Active autoimmune disease with skin involvement.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Eastern Cooperative Oncology Group (ECOG) Performance Status (0-2 for monotherapy; 0-1 for combo)",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) Performance Status (0-2 for monotherapy; 0-1 for combo)",
                    "criterion": "ECOG Performance Status",
                    "requirements": [
                        {
                            "requirement_type": "score range for monotherapy",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        },
                        {
                            "requirement_type": "score range for combination therapy",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Radiation therapy within 2 weeks before first dose of study treatment.",
            "criterions": [
                {
                    "exact_snippets": "Radiation therapy within 2 weeks before first dose of study treatment.",
                    "criterion": "radiation therapy",
                    "requirements": [
                        {
                            "requirement_type": "timing before first dose of study treatment",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Malabsorption syndrome.",
            "criterions": [
                {
                    "exact_snippets": "Malabsorption syndrome.",
                    "criterion": "malabsorption syndrome",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosis of another cancer within 2 years before first dose of study treatment, except for superficial skin cancers, or localized, low-grade tumors deemed cured and not treated with standard therapy.",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of another cancer within 2 years before first dose of study treatment",
                    "criterion": "diagnosis of another cancer",
                    "requirements": [
                        {
                            "requirement_type": "time since diagnosis",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        },
                        {
                            "requirement_type": "timing relative to study treatment",
                            "expected_value": "before first dose"
                        }
                    ]
                },
                {
                    "exact_snippets": "except for superficial skin cancers",
                    "criterion": "superficial skin cancers",
                    "requirements": [
                        {
                            "requirement_type": "exception",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "or localized, low-grade tumors deemed cured and not treated with standard therapy",
                    "criterion": "localized, low-grade tumors",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "deemed cured"
                        },
                        {
                            "requirement_type": "treatment history",
                            "expected_value": "not treated with standard therapy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known history or positive test for human immunodeficiency virus (HIV) unless meets specific criteria.",
            "criterions": [
                {
                    "exact_snippets": "Known history or positive test for human immunodeficiency virus (HIV)",
                    "criterion": "human immunodeficiency virus (HIV) infection",
                    "requirements": [
                        {
                            "requirement_type": "history or test result",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active autoimmune disease with skin involvement.",
            "criterions": [
                {
                    "exact_snippets": "Active autoimmune disease with skin involvement",
                    "criterion": "autoimmune disease",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "skin involvement",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Current or recent severe illness",
            "criterions": [
                {
                    "exact_snippets": "Current or recent severe illness",
                    "criterion": "severe illness",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": [
                                "current",
                                "recent"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of solid organ, autologous or allogenic stem cell transplant.",
            "criterions": [
                {
                    "exact_snippets": "History of solid organ, autologous or allogenic stem cell transplant.",
                    "criterion": "transplant history",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "solid organ transplant",
                                "autologous stem cell transplant",
                                "allogenic stem cell transplant"
                            ]
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants must be eligible for sacituzumab govitecan treatment as their next line of therapy.",
            "criterions": [
                {
                    "exact_snippets": "eligible for sacituzumab govitecan treatment as their next line of therapy",
                    "criterion": "eligibility for sacituzumab govitecan treatment",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "line of therapy",
                            "expected_value": "next"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* For All Participants",
            "criterions": [
                {
                    "exact_snippets": "For All Participants",
                    "criterion": "participant group",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": "all participants"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* At least one but no more than 3 prior lines of therapy.",
            "criterions": [
                {
                    "exact_snippets": "At least one but no more than 3 prior lines of therapy.",
                    "criterion": "number of prior lines of therapy",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "lines"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "lines"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active infection with hepatitis B virus or hepatitis C virus.",
            "criterions": [
                {
                    "exact_snippets": "Active infection with hepatitis B virus",
                    "criterion": "hepatitis B virus infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Active infection with ... hepatitis C virus",
                    "criterion": "hepatitis C virus infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have received at least one standard therapy unless it does not exist, or available therapies are intolerable or no longer effective.",
            "criterions": [
                {
                    "exact_snippets": "Have received at least one standard therapy",
                    "criterion": "standard therapy received",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "therapy"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "unless it does not exist",
                    "criterion": "standard therapy existence",
                    "requirements": [
                        {
                            "requirement_type": "existence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "available therapies are intolerable",
                    "criterion": "tolerability of available therapies",
                    "requirements": [
                        {
                            "requirement_type": "tolerability",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "available therapies are ... no longer effective",
                    "criterion": "effectiveness of available therapies",
                    "requirements": [
                        {
                            "requirement_type": "effectiveness",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior anticancer treatment, including:",
            "criterions": [
                {
                    "exact_snippets": "Prior anticancer treatment",
                    "criterion": "prior anticancer treatment",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known brain metastases or cranial epidural disease",
            "criterions": [
                {
                    "exact_snippets": "Known brain metastases",
                    "criterion": "brain metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "cranial epidural disease",
                    "criterion": "cranial epidural disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* For participants, who qualify for approved molecularly selected therapies such as RAS inhibitors, they must have progressed on, relapsed from, been intolerant to, ineligible, or refused those therapies.",
            "criterions": [
                {
                    "exact_snippets": "qualify for approved molecularly selected therapies such as RAS inhibitors",
                    "criterion": "qualification for approved molecularly selected therapies (e.g., RAS inhibitors)",
                    "requirements": [
                        {
                            "requirement_type": "qualification",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must have progressed on, relapsed from, been intolerant to, ineligible, or refused those therapies",
                    "criterion": "prior therapy with approved molecularly selected therapies (e.g., RAS inhibitors)",
                    "requirements": [
                        {
                            "requirement_type": "prior therapy outcome",
                            "expected_value": [
                                "progressed",
                                "relapsed",
                                "intolerant",
                                "ineligible",
                                "refused"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosis of metastatic advanced UC (primary tumor: renal pelvis, ureter, urinary bladder, or urethra).",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of metastatic advanced UC",
                    "criterion": "urothelial carcinoma (UC)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "stage",
                            "expected_value": "metastatic advanced"
                        }
                    ]
                },
                {
                    "exact_snippets": "primary tumor: renal pelvis, ureter, urinary bladder, or urethra",
                    "criterion": "primary tumor location",
                    "requirements": [
                        {
                            "requirement_type": "anatomical site",
                            "expected_value": [
                                "renal pelvis",
                                "ureter",
                                "urinary bladder",
                                "urethra"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* At least one measurable lesion as defined by RECIST, version 1.1.",
            "criterions": [
                {
                    "exact_snippets": "At least one measurable lesion as defined by RECIST, version 1.1.",
                    "criterion": "measurable lesion",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lesion"
                            }
                        },
                        {
                            "requirement_type": "definition_standard",
                            "expected_value": "RECIST, version 1.1"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Expansion Stage",
            "criterions": [
                {
                    "exact_snippets": "Expansion Stage",
                    "criterion": "study stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "Expansion"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "Inclusion Criteria",
            "criterions": []
        },
        {
            "line": "Exclusion Criteria",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}